Controversies in Management of Locally Advanced, Recurrent and Metastatic Prostate Cancer

Saturday, November 1, 2025

14:00 - 15:30 GMT+0

Co-Chair(s)

At the end of this session, attendees should be able to:

Assess the role of theranostics in managing locally advanced prostate cancer.
Differentiate neoadjuvant and adjuvant treatment strategies for surgically managed locally advanced prostate cancer.
Recognize the role of local, systemic, and metastasis-drectied treatment of recurrent and metatastatic prostate cancer.
Incorporate supportive care strategies, including exercise, into comprehensive prostate cancer management.

14:00 GMT+0

Welcome and Introductions
14:00 - 14:12 GMT+0

Theranostics in Locally Advanced CaP
Speaker: Joseph Ischia – University of Melbourne
14:12 - 14:24 GMT+0

Neo-Adj & Adj Rx of CaP Being Treated Surgically
Speaker: Peter Chiu – The Chinese University of Hong Kong
14:24 - 14:32 GMT+0

Local Therapy
Speaker: Shomik Sengupta – EHCS, Monash University
14:32 - 14:40 GMT+0

Met-Directed Rx
Speaker: Noel Clarke – University of Manchester
14:40 - 14:48 GMT+0

Systemic Rx
Speaker: Stefanie Zschäbitz – University Hospital Heidelberg, Germany
14:48 - 15:00 GMT+0

Current Management of BCR
Speaker: Giuseppe Carrieri – University of Foggia, Italy
15:00 - 15:12 GMT+0

Exercise in CaP
Speaker: Arturo Mendoza-Valdes – Hospital Medica Sur
15:12 - 15:30 GMT+0

Discussion and Concluding Remarks